4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028863
President and CEO gave up 3,455 shares (to pay taxes)
- President and CEO acquired 12,133 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2018-05-07 | Option exercise | +12,133 | 909,317 | D | ||
| Walker Neal President and CEO | 2018-05-07 | Shares withheld for taxes | −3,455 | $18.10 | $62,536 | 905,862 | D |
| Derivatives | |||||||
| Walker Neal President and CEO | 2018-05-07 | Option exercise · Restricted Stock Units | −12,133 | 9,100 | D | ||
Loading xslF345X03/doc4.xml…